Cell Applications, Inc. Strengthens Stem Cell Media Portfolio with Cardiomyocyte Differentiation Kit
SAN DIEGO, Jan 27, 2017 -- Cell Applications, Inc. introduces a specialized medium kit that differentiates Human Induced Pluripotent Stem Cells (HiPSC) into Cardiomyocytes (i-HCm). The i-HCm Differentiation Medium Kit has everything needed: Differentiation, selection and maintenance media. Researchers can access this convenient, effective formula and protocol to make beating heart cells. By applying rigorous quality control, standard operating procedures and Good Manufacturing Practices (GMP), the i-HCm Differentiation Kit allows cell differentiation with lot-to-lot reproducibility and ease. Human Dermal Fibroblasts (HDF) are re-programmed to HiPSC, which can be coaxed into multiple cell lineages, including cardiomyocytes. This latter process typically involves deep knowledge of complex media formulas & procedures, where even a small mistake can wipe out weeks of work. Cardiomyocytes are specialized, contractile and fatigue-resistant heart muscle cells that provide a powerful in vitro model for cardiac physiology and disease modeling. R&D applications include cell physiology, viability, high content screening, drug efficacy, safety and cardiotoxicity.